ATE203513T1 - A FAMILY OF COMPOUNDS HAVING ANTI-INFLAMMATORY AND ANTIVIRAL ACTIVITY AND THEIR COMPOSITIONS ALONE OR IN CONJUNCTION WITH REVERSE TRANSCRIPTASE INHIBITORS FOR INHIBITING, AVOIDING OR ELIMINating VIRAL REPLICATION AND METHODS OF USE THEREOF - Google Patents

A FAMILY OF COMPOUNDS HAVING ANTI-INFLAMMATORY AND ANTIVIRAL ACTIVITY AND THEIR COMPOSITIONS ALONE OR IN CONJUNCTION WITH REVERSE TRANSCRIPTASE INHIBITORS FOR INHIBITING, AVOIDING OR ELIMINating VIRAL REPLICATION AND METHODS OF USE THEREOF

Info

Publication number
ATE203513T1
ATE203513T1 AT96928647T AT96928647T ATE203513T1 AT E203513 T1 ATE203513 T1 AT E203513T1 AT 96928647 T AT96928647 T AT 96928647T AT 96928647 T AT96928647 T AT 96928647T AT E203513 T1 ATE203513 T1 AT E203513T1
Authority
AT
Austria
Prior art keywords
compounds
inflammatory
inhibiting
methods
reverse transcriptase
Prior art date
Application number
AT96928647T
Other languages
German (de)
Inventor
Farid Hamedi-Sangsari
Fabienne Nugier
Thierry Vallet
Jacques Grange
Jorge Vila
Original Assignee
Cie De Dev Aguettant
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cie De Dev Aguettant filed Critical Cie De Dev Aguettant
Application granted granted Critical
Publication of ATE203513T1 publication Critical patent/ATE203513T1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/46—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

A new family of compounds having anti-inflammatory, anti-viral, and brocho-dilating activity having the following linear and cyclic formulas: <IMAGE> I (linear form) <IMAGE> II (cyclic form) and compositions of these, which alone, and in combination with reverse transcriptase inhibitors thereby resulting in an additive or synergistic effect, are useful in inhibiting or suppressing viruses including those exhibiting retroviral replication, or in treating viruses including a retrovirus such as HIV in a human cell population and methods of using these compositions, compounds, and salts thereof.
AT96928647T 1995-09-15 1996-09-13 A FAMILY OF COMPOUNDS HAVING ANTI-INFLAMMATORY AND ANTIVIRAL ACTIVITY AND THEIR COMPOSITIONS ALONE OR IN CONJUNCTION WITH REVERSE TRANSCRIPTASE INHIBITORS FOR INHIBITING, AVOIDING OR ELIMINating VIRAL REPLICATION AND METHODS OF USE THEREOF ATE203513T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US52887995A 1995-09-15 1995-09-15
US08/600,525 US5705522A (en) 1995-09-15 1996-02-13 Compounds having anti-inflammatory and anti-viral activity, compositions of these, alone and in combination with reverse transcriptase inhibitors
PCT/IB1996/000942 WO1997010205A1 (en) 1995-09-15 1996-09-13 A new family of compounds having anti-inflammatory and anti-viral activity and compositions of these, alone and in combination with reverse transcriptase inhibitors, for inhibiting, preventing or eliminating viral replication and methods of using same

Publications (1)

Publication Number Publication Date
ATE203513T1 true ATE203513T1 (en) 2001-08-15

Family

ID=27062862

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96928647T ATE203513T1 (en) 1995-09-15 1996-09-13 A FAMILY OF COMPOUNDS HAVING ANTI-INFLAMMATORY AND ANTIVIRAL ACTIVITY AND THEIR COMPOSITIONS ALONE OR IN CONJUNCTION WITH REVERSE TRANSCRIPTASE INHIBITORS FOR INHIBITING, AVOIDING OR ELIMINating VIRAL REPLICATION AND METHODS OF USE THEREOF

Country Status (8)

Country Link
US (1) US5705522A (en)
EP (1) EP0854860B1 (en)
JP (1) JP2000511871A (en)
AT (1) ATE203513T1 (en)
AU (1) AU6835096A (en)
CA (1) CA2231996A1 (en)
DE (1) DE69614127D1 (en)
WO (1) WO1997010205A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002518452A (en) * 1998-06-24 2002-06-25 エモリ ユニバーシティ Use of 3'-azido-2 ', 3'-dideoxyuridine in combination with other anti-HIV drugs for the manufacture of a therapeutic drug for HIV
JP2003523978A (en) * 2000-02-18 2003-08-12 シャイアー・バイオケム・インコーポレイテッド Methods for treating or preventing FLAVIVIRUS infection using nucleoside analogs
US20050087555A1 (en) * 2003-10-28 2005-04-28 Hatton Jason D. Fluid dispensing components
KR101423898B1 (en) * 2005-12-14 2014-07-28 암브룩스, 인코포레이티드 Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
LT2691530T (en) 2011-06-10 2018-08-10 Oregon Health & Science University Cmv glycoproteins and recombinant vectors

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0206497B1 (en) * 1985-05-15 1994-07-20 The Wellcome Foundation Limited Therapeutic nucleosides and their preparation
WO1987001284A1 (en) * 1985-08-26 1987-03-12 United States Of America, Represented By The Unite Inhibition of in vitro infectivity and cytopathic effect of htlv-iii/lav by 2',3'-dideoxynosine, 2',3'-dideoxyguanosine, or 2',3'-dideoxyadenosine
US5254539A (en) * 1985-08-26 1993-10-19 U.S. Government, Dept. Of Health And Human Services, C/O National Institutes Of Health Method of treating HIV with 2',3'-dideoxyinosine
US5571839A (en) * 1989-04-28 1996-11-05 Institut National De La Sante Et De La Recherche Medicale (Inserm) D-aspartic acid β-hydroxamate for the treatment of viral infections and tumors
FR2646348A1 (en) * 1989-04-28 1990-11-02 Inst Nat Sante Rech Med D-ASPARTIC ACID-HYDROXAMATE AS A MEDICINAL PRODUCT
GB9208428D0 (en) * 1992-04-16 1992-06-03 Proteus Molecular Design Synthetic polypeptides
ATE273700T1 (en) * 1993-05-21 2004-09-15 Us Gov Health & Human Serv NEW METHOD FOR INHIBITING THE REPLICATION OF THE VIRUS-DEPENDENT REVERSE TRANSCIPTASE BY USING DIDEOXYDENUCLEOTIDE SYNTHESIS INHIBITORS
AU1249595A (en) * 1993-12-20 1995-07-17 Compagnie De Developpment Mixtures of dideoxynucleosides and d-aspartic acid beta-hydroxamate for inhibiting retroviral spread

Also Published As

Publication number Publication date
JP2000511871A (en) 2000-09-12
EP0854860B1 (en) 2001-07-25
AU6835096A (en) 1997-04-01
WO1997010205A1 (en) 1997-03-20
US5705522A (en) 1998-01-06
CA2231996A1 (en) 1997-03-20
DE69614127D1 (en) 2001-08-30
EP0854860A1 (en) 1998-07-29

Similar Documents

Publication Publication Date Title
DK0735890T3 (en) Mixtures of 2 &#39;, 3&#39;-dideoxyinosine and hydroxycarbamide to inhibit retroviral spread
ATE91233T1 (en) ANTIVIRAL PHARMACEUTICAL COMPOSITIONS AND THEIR USE.
DE3581819D1 (en) PYRIDAZINE AMINS EFFECTIVE AGAINST VIRUSES.
BG102048A (en) Tetrahydrofuran-containing sulphonamides as aspartylprotease inhibitors
MX9700237A (en) Retroviral protease inhibitor combinations.
BR9911305A (en) Nitrate salts, process for preparing the same, pharmaceutical compositions, and use of them
DK282585A (en) SYNERGISTIC MIXTURES OF INTERFERONES AND TUMOR NECROSIS FACTOR
MX9204454A (en) THIOUREA DERIVATIVES TO INHIBIT THE REPLICATION OF THE HUMAN IMMUNODEFICIENCY VIRUS AND THE PHARMACEUTICAL FORMULATE CONTAINING THEM.
ATE298741T1 (en) POLYAROMATIC COMPOUNDS FOR THE TREATMENT OF HERPES INFECTIONS
DK0741577T3 (en) The use of enterferon, subtype alpha 8, in the manufacture of drugs for the treatment of viral infections in the liver
DE3780016D1 (en) PHARMACEUTICAL PREPARATION WITH 3&#39;-DESOXYTHYMIDIN-2&#39;-EN (3&#39;-DESOXY-2 &#39;, 3&#39;-DIDEHYDROTHYMIDINE) FOR TREATING PATIENTS WITH RETROVIRAL INFECTIONS.
DK0706514T3 (en) Compounds and Methods for Inhibiting HIV and Related Viruses
ATE376445T1 (en) SYNERGISTIC INHIBITION OF VIRAL REPLICATION BY LONG CHAIN HYDROCARBONS AND NUCLEOSIDE ANALOGUES
ATE203513T1 (en) A FAMILY OF COMPOUNDS HAVING ANTI-INFLAMMATORY AND ANTIVIRAL ACTIVITY AND THEIR COMPOSITIONS ALONE OR IN CONJUNCTION WITH REVERSE TRANSCRIPTASE INHIBITORS FOR INHIBITING, AVOIDING OR ELIMINating VIRAL REPLICATION AND METHODS OF USE THEREOF
ES2113888T3 (en) DEXTRIN SULPHATES AS ANTI-HIV-1 AGENTS AND THEIR COMPOSITION.
DE69403063D1 (en) AGAINST VIRUS-ACTIVE NAPHTOCHINONE COMPOUNDS, COMPOSITIONS AND THEIR USE
ATE213231T1 (en) MICHELLAMINE FOR USE AS ANTIVIRAL INGREDIENTS, COMPOSITION AND METHOD OF TREATMENT
MX9302681A (en) NEW QUINAZOLINS AS REVERSE HIV TRANSCRIPTASE INHIBITORS.
ES2134259T3 (en) CALANOLID ANTIVIRIC COMPOUNDS, COMPOSITIONS AND USE THEREOF.
SE9402241D0 (en) Inhibitor
NO934528L (en) Acylated heparins as inhibitors of retroviral replication
ATE114115T1 (en) USE OF 5,6-DIHYDRO-DIBENZ(B,E&gt;AZEPINE-6,11-DION-11-OXIME N FOR THE MANUFACTURE OF ANTIRETROVIRAL AGENTS.
ATE119392T1 (en) SPECIFIC PRODUCT INHIBITOR OF RETROVIRAL REVERSE TRANSCRIPTASE AND ITS USE AS A MEDICINAL PRODUCT.
Devi et al. Clastogenic effect of WR-2721 on mouse chromosomes
ATE179601T1 (en) RESISTANCE OF HIV-1 LINES TO ZIDOVUDINE

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties